Blood test analyzes immune protein changes to detect early-stage tumors and guide treatment

Published Date: 01 Aug 2025

Current methods for cancer diagnosis are based on identifying biomarkers—molecules that reveal a particular state or process in the body—produced by the tumor or associated proteins. Not surprisingly, these markers are ...

Read Full News

Todays Updates


5 Psychiatry Headlines You Missed in September 2026


5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH


An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio


A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio


New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis


Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD


Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.

Todays Updates


5 Psychiatry Headlines You Missed in September 2026


5 Psychiatry Headlines You Missed in September 2026

Givinostat Data Point to Delayed Loss of Ambulation, Preserved Muscle Tissue in DMD Isabella Ciccone, MPH


An updated open-label extension analysis and new MRI data from the phase 3 EPIDYS trial, presented at the 2026 AANEM Annual Meeting, add to the evidence for givinostat's long-term effects on disease progression.

Nipocalimab’s Safety Profile Slightly Favored Over Other Myasthenia Gravis Therapies, Indirect Comparison Shows Marco Meglio


A new Bayesian network meta-analysis found nipocalimab's serious adverse event rates compared favorably with other gMG therapies, while overall adverse event rates were comparable.

Early Spinal Muscular Atrophy Treatment Tied to Milder Pediatric Phenotype Marco Meglio


New data from a Cure SMA survey showed that children treated with disease-modifying therapy soon after birth walk more often and have fewer comorbidities than those treated later.

NeurologyLive® Brain Games: October 4, 2026 Louie Pasculli


Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of MDS!

Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis


Exocrine Pancreatic Insufficiency Estimated in 40% of Chronic Pancreatitis

Corticosteroid Stewardship in Dermatology is Not Steroid Avoidance, With Adam Friedman, MD Adam Friedman, MD, FAAD


Friedman outlines how dermatologists can track cumulative corticosteroid exposure, identify at-risk patients, and improve patient adherence with handouts.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combination Treatment May Improve Multiple Myeloma Outcomes

2.

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

3.

Hospitalized Kate Middleton; Sen. Paul Demands That Fauci Go To Prison; COVID Returns to Class.

4.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

5.

Significant Survival Boost With Novel ADCs in Relapsed Small-Cell Lung Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot